Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases (original) (raw)

References

  1. Rowley JD . A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining Nature 1973 243: 290–293
    Article CAS Google Scholar
  2. Davis RL, Konopka JB, Witte ON . Activation of the c-abl oncogene by viral transduction generates altered c-abl proteins with similar in vitro kinase properties Mol Cell Biol 1985 5: 204–213
    Article CAS Google Scholar
  3. Daley GQ, Van Etten RA, Baltimore D . Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome Science 1990 247: 824–830
    Article CAS Google Scholar
  4. Ganesan TS, Rassool R, Guo A-P, Th'ng KH, Dowding C, Hibbin JA, Young BD, White H, Kumaran TO, Galton DAG, Goldman JM . Rearrangement of the bcr gene in Philadelphia chromosome-negative chronic myeloid leukemia Blood 1986 68: 957–960
    CAS PubMed Google Scholar
  5. Tkachuk DC, Westbrook CA, Andreeff M, Donlon TA, Cleary ML, Suryanarayan K, Homge M, Redner A, Gray J, Pinkel D . Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization Science 1990 250: 559–562
    Article CAS Google Scholar
  6. Kawasaki ES, Clark SS, Coyne MY, Smith SD, Champlin R, Witte ON, McCormick FP . Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro Proc Natl Acad Sci USA 1988 85: 5698–5702
    Article CAS Google Scholar
  7. Reiter A, Skladny H, Hochhaus A, Seifarth W, Heimpel H, Bartram CR, Cross NCP, Hehlmann R . Molecular response of CML patients treated with interferon-a monitored by quantitative Southern blot analysis Br J Haematol 1997 97: 86–93
    Article CAS Google Scholar
  8. Hochhaus A, Weisser A, La Rosée P, Emig M, Müller MC, Saussele S, Reiter A, Kuhn C, Berger U, Hehlmann R, Cross NCP . Detection and quantification of residual disease in chronic myelogenous leukemia Leukemia 2000 14: 998–1005
    Article CAS Google Scholar
  9. Nanjangud G, Kadam PR, Saikia T, Bhisey AN, Kumar A, Gopal R, Chopra H, Nair CN, Advani SH . Karyotypic findings as an independent prognostic marker in chronic myeloid leukaemia blast crisis Leuk Res 1994 18: 385–392
    Article CAS Google Scholar
  10. Mitelman F . The cytogenetic scenario of chronic myeloid leukemia Leuk Lymphoma 1993 11: 11–15
    Article Google Scholar
  11. Cross NC . Minimal residual disease in chronic myeloid leukaemia Hematol Cell Ther 1998 40: 224–228
    CAS PubMed Google Scholar
  12. Seong DC, Kantarjian HM, Ro JY, Talpaz M, Xu J, Robinson JR, Deisseroth AB, Champlin RE, Siciliano MJ . Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatment Blood 1995 86: 2343–2349
    CAS PubMed Google Scholar
  13. Lion T, Izraeli S, Henn T, Gaiger A, Mor W, Gadner H . Monitoring of residual disease in chronic myelogenous leukemia by quantitative polymerase chain reaction Leukemia 1992 6: 495–499
    CAS PubMed Google Scholar
  14. Emig M, Saussele S, Wittor H, Weisser A, Reiter A, Willer A, Berger U, Hehlmann R, Cross NC, Hochhaus A . Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR Leukemia 1999 13: 1825–1832
    Article CAS Google Scholar
  15. Preudhomme C, Revillion F, Merlat A, Hornez L, Roumier C, Duflos Grardel N, Jouet JP, Cosson A, Peyrat JP, Fenaux P . Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a ‘real time’ quantitative RT-PCR assay Leukemia 1999 13: 957–964
    Article CAS Google Scholar
  16. Fonatsch C, Schaadt M, Kirchner H, Diehl V . A possible correlation between the degree of karyotype aberrations and the rate of sister chromatid exchanges in lymphoma lines Int J Cancer 1980 26: 749–756
    Article CAS Google Scholar
  17. ISCN 1995 In: Mitelman F (ed.). Guidelines for Cancer Cytogenetics, Supplement to: An International System for HumanCytogenetic Nomenclature S Karger: Basel 1995
  18. Kantarjian HM, Smith TL, O'Brien S, Beran M, Pierce S, Talpaz M . Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. The Leukemia Service Ann Intern Med 1995 122: 254–261
    Article CAS Google Scholar
  19. Maurer J, Janssen JWG, Thiel E, van Denderen J, Ludwig W-D, Aydemir Ü, Heinze B, Fonatsch C, Harbott J, Reiter A, Riehm H, Hoelzer D, Bartram CR . Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by polymerase chain reaction Lancet 1991 337: 1055–1058
    Article CAS Google Scholar
  20. Seong CM, Giralt S, Kantarjian H, Xu J, Swantkowski J, Hayes K, Glassman AB, Khouri I, Korbling M, Thall P, Siciliano MJ, Champlin RE . Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia J Clin Oncol 2000 18: 1831–1836
    Article CAS Google Scholar
  21. Wilkens L, Varga S, Werner M, Nolte M, v Wasielewski R, Georgii A . Short-term culturing influences the number of bcr/abl-fused cells detected by fluorescence in situ hybridisation in bone marrow aspirates of CML patients Pathobiology 1999 67: 163–168
    Article CAS Google Scholar
  22. Cuneo A, Bigoni R, Emmanuel B, Smit E, Rigolin GM, Roberti MG, Bardi A, Piva N, Scapoli G, Castoldi G, Van Den Berghe H, Hagemeijer A . Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: comparison with metaphase banding analysis Leukemia 1998 12: 1718–1723
    Article CAS Google Scholar
  23. Buno I, Wyatt WA, Zinsmeister AR, Dietz Band J, Silver RT, Dewald GW . A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia Blood 1998 92: 2315–2321
    CAS PubMed Google Scholar
  24. Muhlmann J, Thaler J, Hilbe W, Bechter O, Erdel M, Utermann G, Duba HC . Fluorescence in situ hybridization (FISH) on peripheral blood smears for monitoring Philadelphia chromosome-positive chronic myeloid leukemia (CML) during interferon treatment: a new strategy for remission assessment Genes Chromosomes Cancer 1998 21: 90–100
    Article CAS Google Scholar
  25. Le Gouill S, Talmant P, Milpied N, Daviet A, Ancelot M, Moreau P, Harousseau JL, Bataille R, Avet Loiseau H . Fluorescence in situ hybridization on peripheral-blood specimens is a reliable method to evaluate cytogenetic response in chronic myeloid leukemia J Clin Oncol 2000 18: 1533–1538
    Article CAS Google Scholar
  26. Sinclair PB, Green AR, Grace C, Nacheva EP . Improved sensitivity of BCR-ABL detection: a triple-probe three-color fluorescence in situ hybridization system Blood 1997 90: 1395–1402
    CAS PubMed Google Scholar
  27. Dewald GW, Wyatt WA, Juneau AL, Carlson RO, Zinsmeister AR, Jalal SM, Spurbeck JL, Silver RT . Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia Blood 1998 91: 3357–3365
    CAS PubMed Google Scholar
  28. Radich JP, Gehly G, Gooley T, Bryant E, Clift RA, Collins S, Edmands S, Kirk J, Lee A, Kessler P . Polymerase chain-reaction detection for the bcr-abl fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implication in 346 patients Blood 1995 85: 2632–2640
    CAS PubMed Google Scholar

Download references